Skip to main content

IDWeek 2021 Main banner

Tweets by IDWeek 2021

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

M1. Clinical studies of fungal infections

M1. Clinical studies of fungal infections

Type here to filter the list

975 - Posaconzole for Treatment of Blastomycosis: An Academic Medical Center’s Experience

Favorite
977 - Invasive Mucormycosis in a tertiary care hospital, western Saudi Arabia: 11-year retrospective chart review, from 2009 – 2019

Favorite
978 - Disease Associations and Outcomes in Hospitalized Patients with Non-Cutaneous Mucormycosis: Data from the National Inpatient Sample

Favorite
980 - Universal lifelong fungal prophylaxis and risk of coccidioidomycosis in lung transplant recipients living in an endemic area

Favorite
981 - An Investigation into Possible Nosocomial Clusters and On-Treatment Resistance Patterns in Candidemia

Favorite
982 - Effect of Hepatic Impairment on the Safety and Pharmacokinetics of Rezafungin

Favorite
983 - Outcomes of Candida Bone and Joint Infections in Eight Patients from a Phase 3 Open-label Study (FURI)

Favorite
984 - Diagnostic Utility of Bronchoalveolar Lavage Pneumocystis jirovecii DNA Polymerase Chain Reaction Assay in Patients with Hematological Malignancies and Hematopoietic Cell Transplantation

Favorite
986 - Incidence of Invasive Fungal Infections in Previously Untreated Patients with Acute Myeloid Leukemia Receiving Venetoclax and Azacitadine

Favorite
987 - Clinical epidemiology and outcomes of invasive pulmonary aspergillosis as a complication of respiratory viral infection in hospitalized patients

Favorite
988 - Is There Value of Infectious Diseases Consultation in Candidemia? A Single Center Retrospective Review from 2016-2019

Favorite
989 - Isavuconazonium Sulfate Treatment of Blastomycosis: A Case Series

Favorite
990 - Fungal malignant otitis externa: Clinical and therapeutic features

Favorite
992 - Oral Ibrexafungerp Outcomes in Patients with Oropharyngeal and Esophageal Candidiasis from an Interim Analysis of a Phase 3 Open-label Study (FURI)

Favorite